|drug2158||Lopinavir / ritonavir, alpha-interferon nebulization,Abidor Hydrochloride Wiki||1.00|
|drug1995||Interviews only. Wiki||1.00|
|D018352||Coronavirus Infections NIH||0.04|
There is one clinical trial.
the investigators conduct a randomized, open-label trial to evaluate and compare the safety and efficacy of Xiyanping injection in patients with 2019-nCoV pneumonia.
Description: From the beginning of study drug use to fever, respiratory rate, blood oxygen saturation to normal and cough relief, and maintained for at least 72 hours or more, calculated in hoursMeasure: Clinical recovery time Time: Up to Day 14
Description: From the beginning of research drug use to body temperature <37.3 ℃ (underarm) or mouth temperature ≤37.5 ° C, or anal or ear temperature ≤37.8 ° C, and maintained for 24h or moreMeasure: Complete fever time Time: Up to Day 14
Description: Cough score "day + night" from the beginning of study medication to cough ≤ 1 point, and maintained for 24 hours and aboveMeasure: Cough relief time Time: Up to Day 14
Description: From the beginning of the study drug to two consecutive times (sampling interval of at least 1 day)Measure: Virus negative time Time: Up to Day 14
Description: Defined as the proportion of subjects exacerbated during treatment and meeting the diagnostic criteria for severe or critical neocoronavirus pneumoniaMeasure: Incidence of severe or critical neocoronavirus pneumonia Time: Up to Day 14
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports